bg
N

Novocure (NVCR)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Novocure (NVCR)

NovoCure Limited is a commercial-stage oncology company. The Company is engaged in developing a cancer treatment centered on a therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell divisi... Read more

  • USD17.18
  • USD17.66
  • USD16.91
  • USD34.13
  • 3.00%
  • 622M
  • 20.00
  • 1.59M
  • 2.0B
  • 14.17
  • 9.40%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.